Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Department of Clinical Medicine, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Front Immunol. 2023 Jun 30;14:1215116. doi: 10.3389/fimmu.2023.1215116. eCollection 2023.
Prophylaxis of postoperative recurrence is an intractable problem for clinicians and patients with Crohn's disease. Prognostic models are effective tools for patient stratification and personalised management. This systematic review aimed to provide an overview and critically appraise the existing models for predicting postoperative recurrence of Crohn's disease.
Systematic retrieval was performed using PubMed and Web of Science in January 2022. Original articles on prognostic models for predicting postoperative recurrence of Crohn's disease were included in the analysis. The risk of bias was assessed using the Prediction Model Risk of Bias Assessment (PROBAST) tool. This study was registered with the International Prospective Register of Systematic Reviews (PROSPERO; number CRD42022311737).
In total, 1948 articles were screened, of which 15 were ultimately considered. Twelve studies developed 15 new prognostic models for Crohn's disease and the other three validated the performance of three existing models. Seven models utilised regression algorithms, six utilised scoring indices, and five utilised machine learning. The area under the receiver operating characteristic curve of the models ranged from 0.51 to 0.97. Six models showed good discrimination, with an area under the receiver operating characteristic curve of >0.80. All models were determined to have a high risk of bias in modelling or analysis, while they were at low risk of applicability concerns.
Prognostic models have great potential for facilitating the assessment of postoperative recurrence risk in patients with Crohn's disease. Existing prognostic models require further validation regarding their reliability and applicability.
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022311737.
术后复发的预防对克罗恩病患者和临床医生来说是一个棘手的问题。预后模型是对患者进行分层和个体化管理的有效工具。本系统评价旨在提供对预测克罗恩病术后复发的现有模型的概述和批判性评估。
2022 年 1 月,我们通过 PubMed 和 Web of Science 进行了系统检索。分析中纳入了预测克罗恩病术后复发的预后模型的原始文章。使用预测模型风险偏倚评估工具(PROBAST)评估偏倚风险。本研究在国际前瞻性系统评价注册库(PROSPERO;编号 CRD42022311737)进行了注册。
共筛选出 1948 篇文章,最终纳入了 15 篇。其中 12 项研究开发了 15 个新的克罗恩病预后模型,另外 3 项研究验证了 3 个现有模型的性能。7 个模型使用回归算法,6 个使用评分指数,5 个使用机器学习。模型的受试者工作特征曲线下面积范围为 0.51 至 0.97。6 个模型具有良好的区分度,受试者工作特征曲线下面积>0.80。所有模型在建模或分析方面都存在较高的偏倚风险,而在适用性方面风险较低。
预后模型在评估克罗恩病患者术后复发风险方面具有很大的潜力。现有预后模型需要进一步验证其可靠性和适用性。
https://www.crd.york.ac.uk/PROSPERO/,标识符 CRD42022311737。